{{Rsnum
|rsid=7766973
|Gene=JARID2
|Chromosome=6
|position=15267820
|Orientation=plus
|GMAF=0.4582
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=JARID2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 39.8 | 47.2 | 13.0
| HCB | 27.8 | 54.1 | 18.0
| JPT | 24.8 | 56.6 | 18.6
| YRI | 11.0 | 45.5 | 43.4
| ASW | 9.1 | 49.1 | 41.8
| CHB | 27.8 | 54.1 | 18.0
| CHD | 33.6 | 48.6 | 17.8
| GIH | 0.0 | 0.0 | 0.0
| LWK | 19.0 | 55.2 | 25.7
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 39.0 | 48.0 | 13.0
| HapMapRevision=28
}}[[rs7766973]] is a SNP in the jumonji, AT rich interactive domain 2 [[JARID2]] gene.

Significantly (p = 2 x 10e-7) but weakly associated with [[autism]] based on a GWAS study of 1,000+ affected families. However, upon attempted replication, [[rs7766973]] did not meet genome-wide significance.{{PMID|19812673|OA=1
}}

Nonetheless, a French company (Integragen) announced in 2011 ([http://www.4-traders.com/news/INTEGRAGEN-Announces-Exclusive-Licensing-Agreement-with-The-John-Hopkins-University-and-Massachusett--13599281/] that is was licensing the use of this SNP for identifying children at increased risk for autism, perhaps by combining [[rs7766973]] with other autism-related SNPs.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}